Social Media
Download
Download
Read Mode
Subscribe
Summarize

Overview

Kim Lawton’s practice focuses on capital markets and securities matters, including corporate finance, corporate governance, continuous disclosure, equity compensation, initial and ongoing stock exchange requirements, and market regulation. She advises public and private companies in a wide range of industries with particular emphasis on the life sciences and technology sectors.

She has extensive experience advising entrepreneurs and high-growth companies on a wide range of critical issues on the path to a public listing including selecting prudent incorporation and organizational structures, negotiating a shareholders’ agreement, protecting intellectual property and confidential information, developing contracts with key parties and completing rounds of financing.

Kim is a member of the Women’s Executive Network and Women in Capital Markets and a former executive committee member of the OBA’s Animal Law and IT & IP Law sections. She is also a coach for the Osgoode Mooting Society (Corporate Securities Moot) and a past volunteer at Parkdale Community Legal Services and Artists’ Legal Advice Services.

Before her legal career, Kim was an economist for the Ontario Ministry of Finance, where she provided analytical insight and policy advice on key microeconomic issues relevant to Canadian markets.

Client Work

MustGrow Biologics in its acquisition of NexusBioAg, which provides crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products, from Univar Solutions Canada
Briacell Therapeutics Corp., in its public offering of common shares for gross proceeds of USD$3,050,000
Bloom Burton & Co. and Haywood Securities Inc. in a US$150-million private placement of common shares of Cybin Inc.
TerrAscend Corp., in its arrangement with Canopy USA, LLC to convert $125.5M in debt to securities.
Field Trip Health Ltd., in the spin-out of its drug development and medical clinics businesses into two independent public companies, Reunion Neuroscience and Field Trip Health & Wellness, by plan of arrangement.  The spin-out transaction was supported by a private placement financing led by Oasis Management Company.
A.G.P./Alliance Global Partners, in a US$30-million public offering of units pursuant to a prospectus supplement with Cybin Inc. (NEO: CYBN) (NYSE American: CYBN).

Education & Bar Admissions

Education

  • University of Toronto, BA (Hons.), 2004
  • University of Toronto, MA, 2006
  • Osgoode Hall Law School, JD, 2011

Bar Admissions

  • Ontario, 2012

Insights

Fintech in Canada Q3 2024Blog

Fintech in Canada Q3 2024

November 7, 2024
Matthew FlynnSimon GrantKim Lawton
& 3 more
Investing in RD Stage Healthcare Companies A Recap of BBHIC 2024Blog

Investing in R&D-Stage Healthcare Companies: A Recap of BBHIC 2024

May 2, 2024
Aaron E. SonshineKim Lawton
Aaron E. Sonshine & Kim Lawton